To address the imbalance caused by US domination of molecular biology, the founders of EMBL had a vision of creating a European flagship for the life sciences.
EMBL was founded in 1974 and is funded by contributions from its 21 European member states and two associate member states, Australia and Argentina (as of February 2015).
With nodes in Hinxton (near Cambridge, UK), Grenoble (France), Heidelberg and Hamburg (Germany), and Monterotondo (near Rome, Italy), EMBL comprises about 85 independent research groups and 1760 people from 60 nations.
As well as perform basic research in molecular biology, the cornerstones of EMBL’s mission includes developing new instruments and methods as well as actively engaging in the transfer of relevant technology.
In addition to this, EMBL offers vital services to scientists in the member states. They also provide training for scientists, students and visitors at all levels.
What EMBL offers
- Nine years of funding security for research leaders (subject to performance), after which they move on training for young researchers
- Highly sought postdoctoral positions
- Internationalising research networks across Europe and around the world
- A culture that focuses on mentoring and supporting young scientists and builds strong research alliances.
- EMBL achieves goals beyond the reach of individual member states